Benzodiazepine & Alpha 2 Agonist Dosages Flashcards
Diazepam alternate name:
Valium
Diazepam Structure:
Benzodiazepine
Diazepam MOA:
- Binds to the benzodiazepine binding site located at the subunit cleft between the alpha and gamma subunits of GABA-A receptors
- Binding creates a greater affinity for GABA at the receptor which opens the Cl channel causing Cl influx and hyperpolarization
Diazepam Onset:
3 min
Diazepam Duration of action:
15-30 min
Diazepam PB:
95%
Diazepam Metabolism:
CYP3A4, 2C19, (secondary peak 6-12 h metabolite - desmethyldiazepam), Renal
Diazepam Premedication IV dose:
2-5 mg Q3-4 hr
Diazepam Anticonvulsant dose:
0.1-0.25 mg/kg
Diazepam side effects:
- A - Anxiolysis
- A - Anticonvulsant
- A - Anterograde amnesia
- S - Sedation
- S - Skeletal muscle relaxation
Contraindications/Cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- D - Dose dependent decrease in ventilation
- D - Drowsiness
Midazolam alternate name:
Versed
Midazolam structure:
1, 4 imidazobenzodiazepine derivative
Closed ring (lipid soluble) at physiologic Ph, open ring at lower Ph (around 4)
Midazolam MOA:
- Binds to the benzodiazepine binding site located at the subunit cleft between the alpha and gamma subunits of GABA-A receptors
- Binding creates a greater affinity for GABA at the receptor which opens the Cl channel causing Cl influx and hyperpolarization
Midazolam Onset IV:
1-2 min
Midazolam Duration of action:
15-20 min IV
Midazolam PB:
95%
Midazolam Metabolism:
CYP3A4 to 1-hydroxymidazolam (active metabolite 20% potency), glucuronidation, really excreted
Midazolam Sedation / anxiolytic dose:
1-2.5 mg IV
Midazolam Sedation weight based IV dose:
0.1 mg/kg (max 2mg) Q10 min
Midazolam Side Effects:
- A - Anxiolysis
- A - Anticonvulsant
- A - Anterograde amnesia
- S - Sedation
- S - Skeletal muscle relaxation
Midazolam Contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- D - Dose dependent decrease in ventilation
- D - Drowsiness
Remimazolam alternate name:
Byfavo
Remimazolam structure:
1, 4 imidazobenzodiazepine derivative
Carboxylic acid
Remimazolam MOA:
- Binds to the benzodiazepine binding site located at the subunit cleft between the alpha and gamma subunits of GABA-A receptors
- Binding creates a greater affinity for GABA at the receptor which opens the Cl channel causing Cl influx and hyperpolarization
Remimazolam Onset:
1-2 min
Remimazolam Duration of action:
5-10 min
Remimazolam Protein Binding:
95%
Remimazolam Metabolism:
Rapidly metabolized by nonspecific tissue esterases
Remimazolam IV dose:
0.01-0.5 mg/kg
Remimazolam Side effects:
- A - Anxiolysis
- A - Anticonvulsant
- A - Anterograde amnesia
- S - Sedation
- S - Skeletal muscle relaxation
Remimazolam Contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- D - Dose dependent decrease in ventilation
- D - Drowsiness
Lorazepam alternate name:
Ativan
Lorazepam structure:
Benzodiazepine
Lorazepam MOA:
- Binds to the benzodiazepine binding site located at the subunit cleft between the alpha and gamma subunits of GABA-A receptors
- Binding creates a greater affinity for GABA at the receptor which opens the Cl channel causing Cl influx and hyperpolarization
Lorazepam Onset:
1-2 min
Lorazepam Duration of action:
1-2 h
Lorazepam PB:
95%
Lorazepam Metabolism:
CYP3A4 glucuronidation
Lorazepam anxiety/sedation IV dose:
1-4 mg
Lorazepam Side effects:
- A - Anxiolysis
- A - Anticonvulsant
- A - Anterograde amnesia
- S - Sedation
- S - Skeletal muscle relaxation
Lorazepam Contraindications / cautions
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- D - Dose dependent decrease in ventilation
- D - Drowsiness
Dexmedetomidine alternate name:
Precedex
Dexmedetomidine structure:
S-enantiomer of medetomidine
Dexmedetomidine MOA:
- Alpha 2 agonist (Pontine locus coeruleus)
- Causes K efflux from the cell and hyperpolarization
- Decreased NE release presynaptically
- GPCR: Gi (inhibit adenylyl cyclase = decrease cAMP)
- 1620:1 (alpha 2:alpha 1 affinity)
Dexmedetomidine Onset:
5 min
Dexmedetomidine Duration of action:
1-2 h
Dexmedetomidine PB:
95%
Dexmedetomidine Metabolims:
Hepatic via glucuronidation
Dexmedetomidine IV dose:
0.5 - 1mcg/kg (loading dose over 10 min)
Or can give smaller doses PRN usually 0.05-0.1 mcg/kg for a max of 0.5 - 1mcg/kg
Dexmedetomidine GA adjunct IV infusion dose:
0.2 - 0.4 mcg/kg/hr (1mcg/kg max)
Dexmedetomidine IV infusion dose:
0.2-0.7 mcg/kg/hr
Dexmedetomidine IV MAC infusion dose:
0.7-1 mcg/kg/hr (for 15-20 min, titrate down as able)
Dexmedetomidine Side effects:
- Decreased HR
- Decrease BP
- Decrease opioid requirement
- Spares resp drive
- Decrease CBF (not CMRO2)
Dexmedetomidine Contraindications / cautions:
- Caution In hepatic impairment
- Avoid in low HR (<70)
- Avoid in hypovolemia
- Avoid in low BP
- Does not cause amnesia
- Provides analgesia
Clonidine alternate name:
Catapres
Clonidine structure:
Dichlorobenzene
Clonidine MOA:
- Alpha 2 agonist (Pontine locus coeruleus)
- Causes K efflux from the cell and hyperpolarization
- Decreased NE release presynaptically
- GPCR: Gi (inhibit adenylyl cyclase = decrease cAMP)
- 220:1 (Alpha 2:1 receptor affinity)
Clonidine Onset:
30-60 min
Clonidine duration of action:
3-7 hr
Clonidine PB:
30%
Clonidine Metabolism:
Hepatic, excreted renally 50% unchanged
Clonidine PO dose:
0.1 mg PO
Clonidine side effects:
- Sedation
- Bradycardia
- Dry mouth
- Decreased GI motility
- Decreased sympathetic tone
Clonidine Contraindications / cautions:
- Rebound HTN (do not hold day of surgery)
- Low HR
- Allergy
- Hypotension
5.